| dc.contributor.author | Jennifer Rosendahl | |
| dc.contributor.author | Andreas Svanström | |
| dc.contributor.author | Mattias Berglin | |
| dc.contributor.author | Sarunas Petronis | |
| dc.contributor.author | Yalda Bogestål | |
| dc.contributor.author | Patrik Stenlund | |
| dc.contributor.author | Simon Standoft | |
| dc.contributor.author | Anders Ståhlberg | |
| dc.contributor.author | Göran Landberg | |
| dc.contributor.author | Gary Chinga-Carrasco | |
| dc.contributor.author | Joakim Håkansson | |
| dc.contributor.other | Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, Box 857, SE-50115 Borås, Sweden | |
| dc.contributor.other | Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Box 425, Medicinaregatan 1G, SE-41390 Gothenburg, Sweden | |
| dc.contributor.other | Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, Box 857, SE-50115 Borås, Sweden | |
| dc.contributor.other | Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, Box 857, SE-50115 Borås, Sweden | |
| dc.contributor.other | Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, Box 857, SE-50115 Borås, Sweden | |
| dc.contributor.other | Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, Box 857, SE-50115 Borås, Sweden | |
| dc.contributor.other | Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, Box 857, SE-50115 Borås, Sweden | |
| dc.contributor.other | Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Box 425, Medicinaregatan 1G, SE-41390 Gothenburg, Sweden | |
| dc.contributor.other | Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Box 425, Medicinaregatan 1G, SE-41390 Gothenburg, Sweden | |
| dc.contributor.other | RISE PFI AS, Høgskoleringen 6b, NO-7491 Trondheim, Norway | |
| dc.contributor.other | Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, Box 857, SE-50115 Borås, Sweden | |
| dc.date.accessioned | 2021-07-23T14:30:57Z | |
| dc.date.available | 2025-10-02T04:43:28Z | |
| dc.date.issued | 01-07-2021 | |
| dc.identifier.issn | - | |
| dc.identifier.uri | https://www.mdpi.com/2306-5354/8/7/97 | |
| dc.description.abstract | Current conventional cancer drug screening models based on two-dimensional (2D) cell culture have several flaws and there is a large need of more in vivo mimicking preclinical drug screening platforms. The microenvironment is crucial for the cells to adapt relevant in vivo characteristics and here we introduce a new cell culture system based on three-dimensional (3D) printed scaffolds using cellulose nanofibrils (CNF) pre-treated with 2,2,6,6-tetramethylpyperidine-1-oxyl (TEMPO) as the structural material component. Breast cancer cell lines, MCF7 and MDA-MB-231, were cultured in 3D TEMPO-CNF scaffolds and were shown by scanning electron microscopy (SEM) and histochemistry to grow in multiple layers as a heterogenous cell population with different morphologies, contrasting 2D cultured mono-layered cells with a morphologically homogenous cell population. Gene expression analysis demonstrated that 3D TEMPO-CNF scaffolds induced elevation of the stemness marker <i>CD44</i> and the migration markers <i>VIM</i> and <i>SNAI1</i> in MCF7 cells relative to 2D control. T47D cells confirmed the increased level of the stemness marker <i>CD44</i> and migration marker <i>VIM</i> which was further supported by increased capacity of holoclone formation for 3D cultured cells. Therefore, TEMPO-CNF was shown to represent a promising material for 3D cell culture model systems for cancer cell applications such as drug screening. | |
| dc.format | - | |
| dc.language.iso | EN | |
| dc.publisher | MDPI AG | |
| dc.relation.uri | ['https://www.springernature.com/gp/open-research/policies/journal-policies/apc-waiver-countries', 'https://sustainableearthreviews.biomedcentral.com/submission-guidelines', 'https://sustainableearthreviews.biomedcentral.com/about', 'https://sustainableearthreviews.biomedcentral.com/'] | |
| dc.rights | ['CC BY', 'CC BY-NC-ND'] | |
| dc.subject | ['sustainability', 'sustainable development goals', 'Economic growth, development, planning', 'HD72-88'] | |
| dc.subject.lcc | Technology | |
| dc.title | 3D Printed Nanocellulose Scaffolds as a Cancer Cell Culture Model System | |
| dc.type | Article | |
| dc.description.keywords | nanocellulose | |
| dc.description.keywords | 3D printing | |
| dc.description.keywords | cancer | |
| dc.description.keywords | 3D cell culture | |
| dc.description.keywords | CNF | |
| dc.description.keywords | cancer stemness | |
| dc.description.pages | - | |
| dc.description.doi | 10.3390/bioengineering8070097 | |
| dc.title.journal | Bioengineering | |
| dc.identifier.e-issn | 2306-5354 | |
| dc.identifier.oai | oai:doaj.org/journal:ec6b843993de405d9503480422ef04b9 | |
| dc.journal.info | Volume 8, Issue 7 | |